Faulty Chinese medical gear emerges, as both the US and China adjust their product regulations in response to the pandemic. Dr. Susan Alpert (formerly of the Food of Drug Administration) explains how the FDA regulates products like respirators in normal times, and how regulations are changing – including enforcement through ‘Operation Quack Hack’ – in response to COVID-19 related shortages. Jie Bai (Harvard Kennedy School) shares insights from economic research, including analysis of the regulatory response to a 2008 product safety scandal involving melamine found in Chinese infant dairy formula.

Read more…